Alume Biosciences, Inc. news
Jeremy Richmon, MD is leading a new clinical trial sponsored by Alume, the Center for Clinical Research Operations` (CCRO) first clinical trial with Head and Neck Surgery. The trial involves using a tracer to help identify nerves intraoperatively. This type of cutting edge translational surgical innovation improves outcomes and ultimately the lives of our patients.
The amount of coordination and collaboration that is required across mu
Alume Biosciences, Inc., a clinical stage biotechnology company developing nerve-targeted pharmaceuticals for surgical and therapeutic use, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for its lead compound ALM-488. ALM-488 is an investigational fluoresc
Alume Biosciences, Inc. (Alume) announced today that it has been awarded a $2.5M Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH). This grant will support Alume`s clinical development of its novel nerve illumination technology in surgery. The Principal Investigators on this grant are Michael Whitney
Alume Biosciences announces today that the National Institute of Health (NIH) has honored Dr. Quyen T. Nguyen, MD/PhD, founder of Alume Biosciences and professor of at UC San Diego, in its new website series, Women In Science and Engineering (WISE). Dr. Nguyen is an NIH National Institute of Biomedical Imaging and Bioengineering (NIBIB) grantee. The NIH is committed to creating a supportive environment for all genders in the biomedicine w